Bvf Inc Spring Works Therapeutics, Inc. Transaction History

Bvf Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$65.1 - $93.59 $3,254 - $4,679	-50 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$48.36 - $77.92 $99.3 Million - $160 Million	-2,053,941 Reduced 100.0%	50 $4,000
Q3 2020 Nov 13, 2020	SELL	$36.14 - $51.99 $8.42 Million - $12.1 Million	-232,900 Reduced 10.18%	2,053,991 $97.9 Million
Q2 2020 Aug 14, 2020	SELL	$22.98 - $48.57 $11 Million - $23.3 Million	-480,739 Reduced 17.37%	2,286,891 $96 Million
Q1 2020 May 15, 2020	SELL	$20.44 - $41.21 $6.37 Million - $12.8 Million	-311,525 Reduced 10.12%	2,767,630 $74.7 Million
Q4 2019 Feb 14, 2020	BUY	$17.74 - $39.52 $4.17 Million - $9.29 Million	235,010 Added 8.26%	3,079,155 $119 Million
Q3 2019 Nov 14, 2019	BUY	$18.8 - $27.82 $53.5 Million - $79.1 Million	2,844,145 New	2,844,145 $61.7 Million

238

69.8M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.43B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.